JPWO2023015309A5 - - Google Patents
Info
- Publication number
- JPWO2023015309A5 JPWO2023015309A5 JP2024507108A JP2024507108A JPWO2023015309A5 JP WO2023015309 A5 JPWO2023015309 A5 JP WO2023015309A5 JP 2024507108 A JP2024507108 A JP 2024507108A JP 2024507108 A JP2024507108 A JP 2024507108A JP WO2023015309 A5 JPWO2023015309 A5 JP WO2023015309A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- prime editor
- acid sequence
- prime
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163230688P | 2021-08-06 | 2021-08-06 | |
US63/230,688 | 2021-08-06 | ||
US202263388888P | 2022-07-13 | 2022-07-13 | |
US63/388,888 | 2022-07-13 | ||
PCT/US2022/074628 WO2023015309A2 (en) | 2021-08-06 | 2022-08-05 | Improved prime editors and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2024530487A JP2024530487A (ja) | 2024-08-21 |
JPWO2023015309A5 true JPWO2023015309A5 (enrdf_load_stackoverflow) | 2025-08-20 |
Family
ID=83188605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024507108A Pending JP2024530487A (ja) | 2021-08-06 | 2022-08-05 | 改善されたプライムエディターおよび使用方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20250270593A1 (enrdf_load_stackoverflow) |
EP (1) | EP4381057A2 (enrdf_load_stackoverflow) |
JP (1) | JP2024530487A (enrdf_load_stackoverflow) |
AU (1) | AU2022325166A1 (enrdf_load_stackoverflow) |
CA (1) | CA3227004A1 (enrdf_load_stackoverflow) |
WO (1) | WO2023015309A2 (enrdf_load_stackoverflow) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
WO2018165631A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Cancer vaccine |
JP2020534795A (ja) | 2017-07-28 | 2020-12-03 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物 |
WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
CA3231677A1 (en) | 2021-09-08 | 2023-03-16 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
WO2024077267A1 (en) | 2022-10-07 | 2024-04-11 | The Broad Institute, Inc. | Prime editing methods and compositions for treating triplet repeat disorders |
CN118995664A (zh) * | 2023-05-22 | 2024-11-22 | 江西农业大学 | 基于perv逆转录酶的先导编辑系统 |
WO2024243415A1 (en) | 2023-05-23 | 2024-11-28 | The Broad Institute, Inc. | Evolved and engineered prime editors with improved editing efficiency |
US20250027087A1 (en) | 2023-07-21 | 2025-01-23 | Crispr Therapeutics Ag | Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene |
WO2025048436A1 (ko) * | 2023-08-29 | 2025-03-06 | 성균관대학교산학협력단 | Eys 유전자 교정 프라임 에디터 및 그 용도 |
WO2025096936A2 (en) | 2023-11-03 | 2025-05-08 | The Broad Institute, Inc. | Use of prime editing in correcting mutations in cdkl5 |
WO2025151814A1 (en) | 2024-01-10 | 2025-07-17 | The Broad Institute, Inc. | Use of prime editing in correcting mutations in cftr |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4186183A (en) | 1978-03-29 | 1980-01-29 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in chemotherapy of leishmaniasis |
US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US4774085A (en) | 1985-07-09 | 1988-09-27 | 501 Board of Regents, Univ. of Texas | Pharmaceutical administration systems containing a mixture of immunomodulators |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5244797B1 (en) | 1988-01-13 | 1998-08-25 | Life Technologies Inc | Cloned genes encoding reverse transcriptase lacking rnase h activity |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
WO1991017424A1 (en) | 1990-05-03 | 1991-11-14 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
WO2001038547A2 (en) | 1999-11-24 | 2001-05-31 | Mcs Micro Carrier Systems Gmbh | Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
US8178291B2 (en) | 2005-02-18 | 2012-05-15 | Monogram Biosciences, Inc. | Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors |
US9783791B2 (en) | 2005-08-10 | 2017-10-10 | Agilent Technologies, Inc. | Mutant reverse transcriptase and methods of use |
CN101668848B (zh) | 2007-04-26 | 2014-10-22 | 雷蒙特亚特特拉维夫大学有限公司 | 来自口腔粘膜的多能自体干细胞和使用方法 |
EP2342336B1 (en) | 2008-09-05 | 2016-12-14 | President and Fellows of Harvard College | Continuous directed evolution of proteins and nucleic acids |
CN102421791A (zh) | 2009-03-04 | 2012-04-18 | 得克萨斯系统大学评议会 | 稳定化逆转录酶融合蛋白 |
US8889394B2 (en) | 2009-09-07 | 2014-11-18 | Empire Technology Development Llc | Multiple domain proteins |
US9458484B2 (en) | 2010-10-22 | 2016-10-04 | Bio-Rad Laboratories, Inc. | Reverse transcriptase mixtures with improved storage stability |
EP2655614B1 (en) | 2010-12-22 | 2017-03-15 | President and Fellows of Harvard College | Continuous directed evolution |
CA2850411C (en) | 2011-09-28 | 2023-08-15 | Era Biotech, S.A. | Split inteins and uses thereof |
JP2015522020A (ja) | 2012-06-27 | 2015-08-03 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティThe Trustees Of Princeton University | スプリットインテイン、複合体およびそれらの使用 |
EP2904101B1 (en) | 2012-10-03 | 2019-06-12 | Agrivida, Inc. | Intein-modified proteases, their production and industrial applications |
JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
WO2015134121A2 (en) | 2014-01-20 | 2015-09-11 | President And Fellows Of Harvard College | Negative selection and stringency modulation in continuous evolution systems |
CA2963148C (en) | 2014-10-28 | 2024-04-30 | Agrivida, Inc. | Methods and compositions for stabilizing trans-splicing intein modified proteases |
WO2016168631A1 (en) | 2015-04-17 | 2016-10-20 | President And Fellows Of Harvard College | Vector-based mutagenesis system |
US9580698B1 (en) | 2016-09-23 | 2017-02-28 | New England Biolabs, Inc. | Mutant reverse transcriptase |
US20200140835A1 (en) * | 2017-06-06 | 2020-05-07 | The General Hospital Corporation | Engineered CRISPR-Cas9 Nucleases |
WO2019092042A1 (en) * | 2017-11-10 | 2019-05-16 | Novozymes A/S | Temperature-sensitive cas9 protein |
SG11202109679VA (en) * | 2019-03-19 | 2021-10-28 | Broad Inst Inc | Methods and compositions for editing nucleotide sequences |
WO2021080922A1 (en) * | 2019-10-21 | 2021-04-29 | The Trustees Of Columbia University In The City Of New York | Methods of performing rna templated genome editing |
CA3174486A1 (en) * | 2020-03-04 | 2021-09-10 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
-
2022
- 2022-08-05 US US18/681,490 patent/US20250270593A1/en active Pending
- 2022-08-05 AU AU2022325166A patent/AU2022325166A1/en active Pending
- 2022-08-05 EP EP22764605.6A patent/EP4381057A2/en active Pending
- 2022-08-05 WO PCT/US2022/074628 patent/WO2023015309A2/en active Application Filing
- 2022-08-05 CA CA3227004A patent/CA3227004A1/en active Pending
- 2022-08-05 JP JP2024507108A patent/JP2024530487A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Edwards et al. | Automated DNA sequencing of the human HPRT locus | |
JPWO2023015309A5 (enrdf_load_stackoverflow) | ||
CN109072235B (zh) | 通过核递送crispr/cas9追踪并操纵细胞rna | |
JP2024038327A5 (enrdf_load_stackoverflow) | ||
US5789206A (en) | Method for ligating adaptors to nucleic acids which methods are useful for obtaining the ends of genes | |
JP2022062143A (ja) | 腎臓病の処置のための組成物と方法 | |
JPS62501470A (ja) | 腫瘍壊死因子の精製、製造および使用法 | |
CN108350454A (zh) | 等位基因选择性基因编辑及其用途 | |
JP2002519038A (ja) | 多様性の高いライブラリーを製造する方法 | |
JPS60252496A (ja) | 新規なヒト生理活性ポリペプチド | |
JP2017510542A5 (enrdf_load_stackoverflow) | ||
US5405775A (en) | Retrons coding for hybrid DNA/RNA molecules | |
JP7684298B2 (ja) | Rna分子を合成する方法 | |
AU2022398241A1 (en) | Modified prime editing guide rnas | |
WO2023086842A1 (en) | Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy | |
JPS6070086A (ja) | コロナウイルス用ワクチンの調製方法 | |
AU2022220203A1 (en) | Curing disease by transcription regulatory gene editing | |
CN118922536A (zh) | 分段核酸 | |
JPWO2023004409A5 (enrdf_load_stackoverflow) | ||
JP3680392B2 (ja) | マイクロ遺伝子のランダム重合体作成方法 | |
JPWO2022256440A5 (enrdf_load_stackoverflow) | ||
JPWO2020146521A5 (enrdf_load_stackoverflow) | ||
JPS62226928A (ja) | 臓器機能改善剤 | |
JP4395331B2 (ja) | 核酸検出方法 | |
CN118460655B (zh) | 抑制FXI基因表达的siRNA的制备方法 |